Pune, India

Deepak Babasaheb Nale

This inventor holds 1 USPTO granted patent. Top assignee: Lupin, Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Deepak Babasaheb Nale. Retrieved from https://idiyas.com/inventor/deepak-babasaheb-nale

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Deepak Babasaheb Nale: Innovator in HIV Integrase Inhibitor Synthesis

Introduction

Deepak Babasaheb Nale is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of HIV integrase inhibitors. His work is crucial in the ongoing battle against HIV, providing new avenues for treatment.

Latest Patents

Deepak Nale holds a patent for a process for the preparation of intermediates used for the synthesis of HIV integrase inhibitors. This patent includes the synthesis of compounds such as Bictegravir, Dolutegravir, and Cabotegravir, along with their pharmaceutically acceptable salts. His innovative approach enhances the efficiency and effectiveness of these important medications.

Career Highlights

Deepak Nale is currently employed at Lupin, Inc., a leading global pharmaceutical company. His role involves research and development, focusing on creating advanced therapeutic solutions. His expertise in medicinal chemistry has positioned him as a key player in the pharmaceutical industry.

Collaborations

Throughout his career, Deepak has collaborated with talented professionals, including Harishchandra Sambhaji Jadhav and Dhananjai Shrivastava. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their field.

Conclusion

Deepak Babasaheb Nale's contributions to the synthesis of HIV integrase inhibitors highlight his importance in the pharmaceutical industry. His innovative work continues to pave the way for new treatments, making a lasting impact on public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…